Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer

NCT00066573 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7576

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: anastrozole
DRUG: exemestane

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]